{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:01:06Z","timestamp":1784685666537,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92359202 and 62425112"],"award-info":[{"award-number":["92359202 and 62425112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["RCJC20200714114557005 and JCYJ20220818100015031"],"award-info":[{"award-number":["RCJC20200714114557005 and JCYJ20220818100015031"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","award":["2022C003"],"award-info":[{"award-number":["2022C003"]}],"id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73632-w","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:36:07Z","timestamp":1779888967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrence in the chemotherapy regimen of bladder carcinoma originates from quiescent epidermoid-like cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Dewang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0578-9174","authenticated-orcid":false,"given":"Xinchen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-2101","authenticated-orcid":false,"given":"Shang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daitian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9958-2474","authenticated-orcid":false,"given":"Haoxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-6397","authenticated-orcid":false,"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-5020","authenticated-orcid":false,"given":"Jean Paul","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3504-1630","authenticated-orcid":false,"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"73632_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"73632_CR2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s43018-022-00402-0","volume":"3","author":"A Alvarez-Varela","year":"2022","unstructured":"Alvarez-Varela, A. et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nat. Cancer 3, 1052\u20131070 (2022).","journal-title":"Nat. Cancer"},{"key":"73632_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41586-023-06342-8","volume":"620","author":"Y Goyal","year":"2023","unstructured":"Goyal, Y. et al. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature 620, 651\u2013659 (2023).","journal-title":"Nature"},{"key":"73632_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02320-7","volume":"8","author":"D Liu","year":"2017","unstructured":"Liu, D. et al. Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer. Nat. Commun. 8, 2193 (2017).","journal-title":"Nat. Commun."},{"key":"73632_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/ng.3692","volume":"48","author":"BM Faltas","year":"2016","unstructured":"Faltas, B. M. et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat. Genet. 48, 1490\u20131499 (2016).","journal-title":"Nat. Genet."},{"key":"73632_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017).","journal-title":"Nature"},{"key":"73632_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang, N., Ma, T. & Yu, B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target Ther. 8, 69 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"73632_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05838-7","volume":"616","author":"M Debaugnies","year":"2023","unstructured":"Debaugnies, M. et al. RHOJ controls EMT-associated resistance to chemotherapy. Nature 616, 168\u2013175 (2023).","journal-title":"Nature"},{"key":"73632_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"73632_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ccell.2022.08.010","volume":"40","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell 40, 1044\u20131059 e1048 (2022).","journal-title":"Cancer Cell"},{"key":"73632_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","volume":"596","author":"Y Oren","year":"2021","unstructured":"Oren, Y. et al. Cycling cancer persister cells arise from lineages with distinct programs. Nature 596, 576\u2013582 (2021).","journal-title":"Nature"},{"key":"73632_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41375-022-01755-2","volume":"37","author":"VY Ling","year":"2023","unstructured":"Ling, V. Y. et al. Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia. Leukemia 37, 143\u2013153 (2023).","journal-title":"Leukemia"},{"key":"73632_CR13","doi-asserted-by":"publisher","first-page":"eaba6110","DOI":"10.1126\/scitranslmed.aba6110","volume":"13","author":"B Oresta","year":"2021","unstructured":"Oresta, B. et al. Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer. Sci. Transl. Med. 13, eaba6110 (2021).","journal-title":"Sci. Transl. Med."},{"key":"73632_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101224","volume":"4","author":"Y Kim","year":"2023","unstructured":"Kim, Y. et al. Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer. Cell Rep. Med. 4, 101224 (2023).","journal-title":"Cell Rep. Med."},{"key":"73632_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","volume":"183","author":"S Shen","year":"2020","unstructured":"Shen, S., Vagner, S. & Robert, C. Persistent cancer cells: the deadly survivors. Cell 183, 860\u2013874 (2020).","journal-title":"Cell"},{"key":"73632_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nm.4091","volume":"22","author":"TG Bivona","year":"2016","unstructured":"Bivona, T. G. & Doebele, R. C. A framework for understanding and targeting residual disease in oncogene-driven solid cancers. Nat. Med. 22, 472\u2013478 (2016).","journal-title":"Nat. Med."},{"key":"73632_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tcb.2023.10.002","volume":"34","author":"FJH Whiting","year":"2024","unstructured":"Whiting, F. J. H., Househam, J., Baker, A. M., Sottoriva, A. & Graham, T. A. Phenotypic noise and plasticity in cancer evolution. Trends Cell Biol. 34, 451\u2013464 (2024).","journal-title":"Trends Cell Biol."},{"key":"73632_CR18","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41375-021-01153-0","volume":"35","author":"F Rapaport","year":"2021","unstructured":"Rapaport, F. et al. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia. Leukemia 35, 2688\u20132692 (2021).","journal-title":"Leukemia"},{"key":"73632_CR19","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1200\/JCO.23.00570","volume":"41","author":"LK Hilton","year":"2023","unstructured":"Hilton, L. K. et al. Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma. J. Clin. Oncol. 41, 4164\u20134177 (2023).","journal-title":"J. Clin. Oncol."},{"key":"73632_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.molonc.2010.04.010","volume":"4","author":"NE Navin","year":"2010","unstructured":"Navin, N. E. & Hicks, J. Tracing the tumor lineage. Mol. Oncol. 4, 267\u2013283 (2010).","journal-title":"Mol. Oncol."},{"key":"73632_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23\u201328 (1976).","journal-title":"Science"},{"key":"73632_CR22","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236 (2018)."},{"key":"73632_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh, J. Y. et al. Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat. Rev. Urol. 19, 280\u2013294 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"73632_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio, A. I., Varley, K. E. & Welm, A. L. The lingering mysteries of metastatic recurrence in breast cancer. Br. J. Cancer 124, 13\u201326 (2021).","journal-title":"Br. J. Cancer"},{"key":"73632_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cell.2018.02.001","volume":"172","author":"X Han","year":"2018","unstructured":"Han, X. et al. Mapping the mouse cell atlas by microwell-seq. Cell 172, 1091\u20131107 (2018).","journal-title":"Cell"},{"key":"73632_CR26","doi-asserted-by":"publisher","first-page":"eaba7721","DOI":"10.1126\/science.aba7721","volume":"370","author":"J Cao","year":"2020","unstructured":"Cao, J. et al. A human cell atlas of fetal gene expression. Science 370, eaba7721 (2020).","journal-title":"Science"},{"key":"73632_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.cell.2022.04.015","volume":"185","author":"D Yang","year":"2022","unstructured":"Yang, D. et al. Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. Cell 185, 1905\u20131923 (2022).","journal-title":"Cell"},{"key":"73632_CR28","doi-asserted-by":"publisher","first-page":"dev169730","DOI":"10.1242\/dev.169730","volume":"146","author":"A McKenna","year":"2019","unstructured":"McKenna, A. & Gagnon, J. A. Recording development with single cell dynamic lineage tracing. Development 146, dev169730 (2019).","journal-title":"Development"},{"key":"73632_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","volume":"21","author":"DE Wagner","year":"2020","unstructured":"Wagner, D. E. & Klein, A. M. Lineage tracing meets single-cell omics: opportunities and challenges. Nat. Rev. Genet. 21, 410\u2013427 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"73632_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nbt.4124","volume":"36","author":"B Spanjaard","year":"2018","unstructured":"Spanjaard, B. et al. Simultaneous lineage tracing and cell-type identification using CRISPR-Cas9-induced genetic scars. Nat. Biotechnol. 36, 469\u2013473 (2018).","journal-title":"Nat. Biotechnol."},{"key":"73632_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk, M. et al. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) \u2212 2019 update. Eur. Urol. 76, 639\u2013657 (2019).","journal-title":"Eur. Urol."},{"key":"73632_CR32","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: a review. JAMA 324, 1980\u20131991 (2020).","journal-title":"JAMA"},{"key":"73632_CR33","doi-asserted-by":"publisher","first-page":"eabc1944","DOI":"10.1126\/science.abc1944","volume":"371","author":"JJ Quinn","year":"2021","unstructured":"Quinn, J. J. et al. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science 371, eabc1944 (2021).","journal-title":"Science"},{"key":"73632_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41596-018-0112-8","volume":"14","author":"G Lorenzatti Hiles","year":"2019","unstructured":"Lorenzatti Hiles, G. et al. A surgical orthotopic approach for studying the invasive progression of human bladder cancer. Nat. Protoc. 14, 738\u2013755 (2019).","journal-title":"Nat. Protoc."},{"key":"73632_CR35","doi-asserted-by":"publisher","first-page":"e03568","DOI":"10.7554\/eLife.03568","volume":"3","author":"RA Neher","year":"2014","unstructured":"Neher, R. A., Russell, C. A. & Shraiman, B. I. Predicting evolution from the shape of genealogical trees. Elife 3, e03568 (2014).","journal-title":"Elife"},{"key":"73632_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-018-0128-6","volume":"50","author":"MJ Williams","year":"2018","unstructured":"Williams, M. J. et al. Quantification of subclonal selection in cancer from bulk sequencing data. Nat. Genet. 50, 895\u2013903 (2018).","journal-title":"Nat. Genet."},{"key":"73632_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02000-8","volume":"21","author":"MG Jones","year":"2020","unstructured":"Jones, M. G. et al. Inference of single-cell phylogenies from lineage tracing data using Cassiopeia. Genome Biol. 21, 92 (2020).","journal-title":"Genome Biol."},{"key":"73632_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34251-3","volume":"13","author":"JI Warrick","year":"2022","unstructured":"Warrick, J. I. et al. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. Nat. Commun. 13, 6575 (2022).","journal-title":"Nat. Commun."},{"key":"73632_CR39","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1158\/0008-5472.CAN-21-1254","volume":"81","author":"S Park","year":"2021","unstructured":"Park, S. et al. Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression. Cancer Res. 81, 5161\u20135175 (2021).","journal-title":"Cancer Res."},{"key":"73632_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1101\/gad.1772909","volume":"23","author":"AM Puzio-Kuter","year":"2009","unstructured":"Puzio-Kuter, A. M. et al. Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 23, 675\u2013680 (2009).","journal-title":"Genes Dev."},{"key":"73632_CR41","doi-asserted-by":"publisher","first-page":"eaaw3381","DOI":"10.1126\/science.aaw3381","volume":"367","author":"C Weinreb","year":"2020","unstructured":"Weinreb, C., Rodriguez-Fraticelli, A., Camargo, F. D. & Klein, A. M. Lineage tracing on transcriptional landscapes links state to fate during differentiation. Science 367, eaaw3381 (2020).","journal-title":"Science"},{"key":"73632_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic, M. et al. Senescence-associated reprogramming promotes cancer stemness. Nature 553, 96\u2013100 (2018).","journal-title":"Nature"},{"key":"73632_CR43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"73632_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature14898","volume":"525","author":"P Rathert","year":"2015","unstructured":"Rathert, P. et al. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature 525, 543\u2013547 (2015).","journal-title":"Nature"},{"key":"73632_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim, C. et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173, 879\u2013893 (2018).","journal-title":"Cell"},{"key":"73632_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","volume":"38","author":"ND Marjanovic","year":"2020","unstructured":"Marjanovic, N. D. et al. Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell 38, 229\u2013246 (2020).","journal-title":"Cancer Cell"},{"key":"73632_CR47","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182, 1232\u20131251 (2020).","journal-title":"Cell"},{"key":"73632_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ccell.2020.06.006","volume":"38","author":"LM LaFave","year":"2020","unstructured":"LaFave, L. M. et al. Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma. Cancer Cell 38, 212\u2013228 (2020).","journal-title":"Cancer Cell"},{"key":"73632_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"73632_CR50","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s10147-019-01409-x","volume":"24","author":"A Dotson","year":"2019","unstructured":"Dotson, A. et al. Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy. Int J. Clin. Oncol. 24, 706\u2013711 (2019).","journal-title":"Int J. Clin. Oncol."},{"key":"73632_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3520-1","volume":"17","author":"G Li","year":"2017","unstructured":"Li, G. et al. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. BMC Cancer 17, 530 (2017).","journal-title":"BMC Cancer"},{"key":"73632_CR52","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1016\/j.cub.2020.01.004","volume":"30","author":"RS Moreci","year":"2020","unstructured":"Moreci, R. S. & Lechler, T. Epidermal structure and differentiation. Curr. Biol. 30, R144\u2013R149 (2020).","journal-title":"Curr. Biol."},{"key":"73632_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.31083\/j.fbl2712325","volume":"27","author":"D Qin","year":"2022","unstructured":"Qin, D., Ma, L. & Qin, L. Potential role of the epidermal differentiation complex in the pathogenesis of psoriasis. Front Biosci. 27, 325 (2022).","journal-title":"Front Biosci."},{"key":"73632_CR54","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.annonc.2025.05.536","volume":"36","author":"TB Powles","year":"2025","unstructured":"Powles, T. B. et al. Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302\/KEYNOTE-A39 trial. Ann. Oncol. 36, 1212\u20131219 (2025).","journal-title":"Ann. Oncol."},{"key":"73632_CR55","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s11864-023-01114-y","volume":"24","author":"R Alameddine","year":"2023","unstructured":"Alameddine, R., Mallea, P., Shahab, F. & Zakharia, Y. Antibody drug conjugates in bladder cancer: current milestones and future perspectives. Curr. Treat. Options Oncol. 24, 1167\u20131182 (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"73632_CR56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1200\/JCO.22.02912","volume":"42","author":"X Sheng","year":"2024","unstructured":"Sheng, X. et al. Efficacy and safety of disitamab vedotin in patients with human epidermal growth factor receptor 2-positive locally advanced or metastatic urothelial carcinoma: a combined analysis of two phase II clinical trials. J. Clin. Oncol. 42, 1391\u20131402 (2024).","journal-title":"J. Clin. Oncol."},{"key":"73632_CR57","doi-asserted-by":"crossref","unstructured":"Sheng, X. et al. Disitamab vedotin plus toripalimab in HER2-expressing advanced urothelial cancer. N. Engl. J. Med. 393, 2324\u20132337 (2025).","DOI":"10.1056\/NEJMoa2511648"},{"key":"73632_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi7453","volume":"384","author":"MA Taylor","year":"2024","unstructured":"Taylor, M. A. et al. Stem-cell states converge in multistage cutaneous squamous cell carcinoma development. Science 384, eadi7453 (2024).","journal-title":"Science"},{"key":"73632_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature14034","volume":"517","author":"AV Kurtova","year":"2015","unstructured":"Kurtova, A. V. et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 517, 209\u2013213 (2015).","journal-title":"Nature"},{"key":"73632_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1158\/1078-0432.CCR-15-1169","volume":"23","author":"WJ Wang","year":"2017","unstructured":"Wang, W. J. et al. Inhibition of the EGFR\/STAT3\/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder. Clin. Cancer Res. 23, 503\u2013513 (2017).","journal-title":"Clin. Cancer Res."},{"key":"73632_CR61","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1158\/1078-0432.CCR-04-2409","volume":"11","author":"E Blaveri","year":"2005","unstructured":"Blaveri, E. et al. Bladder cancer outcome and subtype classification by gene expression. Clin. Cancer Res. 11, 4044\u20134055 (2005).","journal-title":"Clin. Cancer Res."},{"key":"73632_CR62","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1038\/onc.2017.149","volume":"36","author":"AL Han","year":"2017","unstructured":"Han, A. L. et al. Fibulin-3 promotes muscle-invasive bladder cancer. Oncogene 36, 5243\u20135251 (2017).","journal-title":"Oncogene"},{"key":"73632_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping, Q. et al. TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J. Transl. Med. 21, 475 (2023).","journal-title":"J. Transl. Med."},{"key":"73632_CR64","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.urolonc.2011.12.003","volume":"31","author":"H Hu","year":"2013","unstructured":"Hu, H. et al. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Urol. Oncol. 31, 1242\u20131253 (2013).","journal-title":"Urol. Oncol."},{"key":"73632_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-018-0388-6","volume":"18","author":"J Ye","year":"2018","unstructured":"Ye, J. et al. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer. BMC Urol. 18, 82 (2018).","journal-title":"BMC Urol."},{"key":"73632_CR66","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi, L., Pan, H., Liu, Z., Xie, J. & Han, W. Roles of PFKFB3 in cancer. Signal Transduct. Target Ther. 2, 17044 (2017).","journal-title":"Signal Transduct. Target Ther."},{"key":"73632_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-023-01383-x","volume":"8","author":"ZD Shi","year":"2023","unstructured":"Shi, Z. D. et al. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduct. Target Ther. 8, 113 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"73632_CR68","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A Perez-Gonzalez","year":"2023","unstructured":"Perez-Gonzalez, A., Bevant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer 4, 1063\u20131082 (2023).","journal-title":"Nat. Cancer"},{"key":"73632_CR69","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41592-024-02567-1","volume":"22","author":"M Chen","year":"2025","unstructured":"Chen, M., Fu, R., Chen, Y., Li, L. & Wang, S. W. High-resolution, noninvasive single-cell lineage tracing in mice and humans based on DNA methylation epimutations. Nat. Methods 22, 488\u2013498 (2025).","journal-title":"Nat. Methods"},{"key":"73632_CR70","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrurol.2018.22","volume":"15","author":"AH Davies","year":"2018","unstructured":"Davies, A. H., Beltran, H. & Zoubeidi, A. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. Nat. Rev. Urol. 15, 271\u2013286 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"73632_CR71","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","volume":"84","author":"KE Rodarte","year":"2024","unstructured":"Rodarte, K. E. et al. Neuroendocrine differentiation in prostate cancer requires ASCL1. Cancer Res. 84, 3522\u20133537 (2024).","journal-title":"Cancer Res."},{"key":"73632_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.eururo.2004.09.007","volume":"47","author":"N Vashchenko","year":"2005","unstructured":"Vashchenko, N. & Abrahamsson, P. A. Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur. Urol. 47, 147\u2013155 (2005).","journal-title":"Eur. Urol."},{"key":"73632_CR73","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","volume":"637","author":"A Moorman","year":"2025","unstructured":"Moorman, A. et al. Progressive plasticity during colorectal cancer metastasis. Nature 637, 947\u2013954 (2025).","journal-title":"Nature"},{"key":"73632_CR74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1158\/2159-8290.CD-15-1192","volume":"6","author":"SJ Klempner","year":"2016","unstructured":"Klempner, S. J. et al. BRAFV600E Mutations in high-grade colorectal neuroendocrine tumors may predict responsiveness to BRAF-MEK combination therapy. Cancer Discov. 6, 594\u2013600 (2016).","journal-title":"Cancer Discov."},{"key":"73632_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ccell.2024.01.012","volume":"42","author":"X Tong","year":"2024","unstructured":"Tong, X. et al. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer Cell 42, 413\u2013428 (2024).","journal-title":"Cancer Cell"},{"key":"73632_CR76","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/1078-0432.CCR-19-3563","volume":"26","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. et al. Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer. Clin. Cancer Res. 26, 2654\u20132663 (2020).","journal-title":"Clin. Cancer Res."},{"key":"73632_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A. et al. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat. Cancer 1, 59\u201374 (2020).","journal-title":"Nat. Cancer"},{"key":"73632_CR78","doi-asserted-by":"publisher","first-page":"e53381","DOI":"10.7554\/eLife.53381","volume":"9","author":"TD Somerville","year":"2020","unstructured":"Somerville, T. D. et al. Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. Elife 9, e53381 (2020).","journal-title":"Elife"},{"key":"73632_CR79","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","volume":"631","author":"GS Franca","year":"2024","unstructured":"Franca, G. S. et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature 631, 876\u2013883 (2024).","journal-title":"Nature"},{"key":"73632_CR80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/0008-5472.CAN-23-1067","volume":"84","author":"A Mehta","year":"2024","unstructured":"Mehta, A. & Stanger, B. Z. Lineage plasticity: the new cancer hallmark on the block. Cancer Res. 84, 184\u2013191 (2024).","journal-title":"Cancer Res."},{"key":"73632_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","volume":"20","author":"BB Liau","year":"2017","unstructured":"Liau, B. B. et al. Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance. Cell Stem Cell 20, 233\u2013246 (2017).","journal-title":"Cell Stem Cell"},{"key":"73632_CR82","doi-asserted-by":"publisher","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science 357, eaal2380 (2017).","journal-title":"Science"},{"key":"73632_CR83","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415\u2013428 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"73632_CR84","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies, A., Zoubeidi, A., Beltran, H. & Selth, L. A. The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov. 13, 1771\u20131788 (2023).","journal-title":"Cancer Discov."},{"key":"73632_CR85","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"73632_CR86","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.trecan.2024.08.005","volume":"10","author":"BN Gantner","year":"2024","unstructured":"Gantner, B. N. et al. Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes. Trends Cancer 10, 992\u20131008 (2024).","journal-title":"Trends Cancer"},{"key":"73632_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18730-z","volume":"11","author":"A Walens","year":"2020","unstructured":"Walens, A. et al. Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nat. Commun. 11, 5017 (2020).","journal-title":"Nat. Commun."},{"key":"73632_CR88","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/ijc.31869","volume":"144","author":"D Fiedler","year":"2019","unstructured":"Fiedler, D. et al. Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence. Int. J. Cancer 144, 1561\u20131573 (2019).","journal-title":"Int. J. Cancer"},{"key":"73632_CR89","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ccell.2018.07.013","volume":"34","author":"C Hurst","year":"2018","unstructured":"Hurst, C., Rosenberg, J. & Knowles, M. SnapShot: Bladder Cancer. Cancer Cell 34, 350\u2013350 (2018).","journal-title":"Cancer Cell"},{"key":"73632_CR90","doi-asserted-by":"publisher","unstructured":"Amin, M. B. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod. Pathol. https:\/\/doi.org\/10.1038\/modpathol.2009.26 (2009).","DOI":"10.1038\/modpathol.2009.26"},{"key":"73632_CR91","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796\u20132810 (2016).","journal-title":"Lancet"},{"key":"73632_CR92","doi-asserted-by":"crossref","unstructured":"Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466\u2013465 (2006).","DOI":"10.1016\/j.eururo.2005.12.031"},{"key":"73632_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"73632_CR94","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41592-021-01282-5","volume":"18","author":"T Stuart","year":"2021","unstructured":"Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state analysis with Signac. Nat. Methods 18, 1333\u20131341 (2021).","journal-title":"Nat. Methods"},{"key":"73632_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14766-3","volume":"11","author":"K Van den Berge","year":"2020","unstructured":"Van den Berge, K. et al. Trajectory-based differential expression analysis for single-cell sequencing data. Nat. Commun. 11, 1201 (2020).","journal-title":"Nat. Commun."},{"key":"73632_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12235-0","volume":"10","author":"D DeTomaso","year":"2019","unstructured":"DeTomaso, D. et al. Functional interpretation of single cell similarity maps. Nat. Commun. 10, 4376 (2019).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73632-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73632-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73632-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:02:28Z","timestamp":1784682148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73632-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73632"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73632-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6902"}}